Download PDF
Horm Metab Res 2021; 53(01): 49-55
DOI: 10.1055/a-1229-1604
Endocrine Care

Associations of the LPL S447X and Hind III Polymorphism with Type 2 Diabetes Mellitus Risk: A Meta-Analysis

Na Liu‡
1   Department of Neurology, Xuzhou Children’s Hospital, Xuzhou Medical University, Xuzhou, China
,
Yan Sang‡
1   Department of Neurology, Xuzhou Children’s Hospital, Xuzhou Medical University, Xuzhou, China
,
Shengzhi Chen
1   Department of Neurology, Xuzhou Children’s Hospital, Xuzhou Medical University, Xuzhou, China
,
Xiaoming Liu
1   Department of Neurology, Xuzhou Children’s Hospital, Xuzhou Medical University, Xuzhou, China
› Author Affiliations
› Further Information
Also available at
    Permissions and Reprints

Abstract

The present study was aimed to evaluate the association of lipoprotein lipase (LPL) gene (S447X and Hind III) polymorphisms and T2DM. Relevant studies were identified through systematic search PubMed, Cochrane Library, Embase, Wanfang, CNKI databases. A total of 22 studies (8 studies for LPL S447X and 14 studies for Hind III) were included. The results showed that the LPL S447X polymorphism was associated with the low risk of T2DM under dominant and allelic genetic models. Subgroup analysis by ethnicity showed that the LPL S447X polymorphism was associated with a decreased risk of T2DM in the Asian population (under dominant, heterozygous and allelic genetic models). In addition, we found that X allele carriers of S447X polymorphism is associated with low levels of TC, TG, and LDL. In subgroup analysis, Hind III polymorphism was associated with low risk of T2DM in Asian populations (under dominant, heterozygote, allele genetic models). Moreover, the carriers of H allele of Hind III have lower levels of TG, and higher levels of HDL-C. This meta-analysis demonstrated that 447X carriers and H allele in LPL gene associated with low risk of T2DM, which may due to in part to the change of serum level of TC, TG, LDL, and HDL.

Key words

lipoprotein lipase - polymorphism - type 2 diabetes mellitus - S447X - Hind III

Supplementary Material



Publication History

Received: 12 May 2020

Accepted after revision: 20 July 2020

Article published online:
04 September 2020

© 2020. Thieme. All rights reserved.

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany

 

  • References

  • 1 Lowell BB, Shulman GI. Mitochondrial dysfunction and type 2 diabetes. Science 2005; 307: 384-387
    CrossrefPubMedGoogle Scholar
  • 2 Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: Diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 1998; 15: 539-553
    CrossrefPubMedGoogle Scholar
  • 3 Wu L, Parhofer KG. Diabetic dyslipidemia. Metabolism 2014; 63: 1469-1479
    CrossrefPubMedGoogle Scholar
  • 4 Momin AA, Bankar MP, Bhoite GM. Study of common genetic variant S447X in lipoprotein lipase and its association with lipids and lipoproteins in type 2 diabetic patients. Indian J Clin Biochem 2016; 31: 286-293
    CrossrefPubMedGoogle Scholar
  • 5 Ravid M, Brosh D, Ravid-Safran D. et al. Main risk factors for nephropathy in type 2 diabetes mellitus are plasma cholesterol levels, mean blood pressure, and hyperglycemia. Arch Intern Med 1998; 158: 998-1004
    CrossrefPubMedGoogle Scholar
  • 6 Johansen CT, Hegele RA. Genetic bases of hypertriglyceridemic phenotypes. Curr Opin Lipidol 2011; 22: 247-253
    CrossrefPubMedGoogle Scholar
  • 7 Henderson HE, Kastelein JJ, Zwinderman AH. et al. Lipoprotein lipase activity is decreased in a large cohort of patients with coronary artery disease and is associated with changes in lipids and lipoproteins. J Lipid Res 1999; 40: 735-743
    CrossrefPubMedGoogle Scholar
  • 8 Young SG, Zechner R. Biochemistry and pathophysiology of intravascular and intracellular lipolysis. Genes Dev 2013; 27: 459-484
    CrossrefPubMedGoogle Scholar
  • 9 Gu B, Zhao YC, Yang ZW. et al. Hind III polymorphism in the lipoprotein lipase gene and hypertensive intracerebral hemorrhage in the Chinese Han population. J Stroke Cerebrovasc Dis 2014; 23: 1275-1281
    CrossrefPubMedGoogle Scholar
  • 10 Wang H, Eckel RH. Lipoprotein lipase: From gene to obesity. Am J Physiol Endocrinol Metab 2009; 297: E271-E288
    CrossrefPubMedGoogle Scholar
  • 11 Askari G, Heidari-Beni M, Mansourian M. et al. Interaction of lipoprotein lipase polymorphisms with body mass index and birth weight to modulate lipid profiles in children and adolescents: the CASPIAN-III Study. Sao Paulo Med J 2016; 134: 121-129
    CrossrefPubMedGoogle Scholar
  • 12 Rip J, Nierman MC, Ross CJ. et al. Lipoprotein lipase S447X: A naturally occurring gain-of-function mutation. Arterioscler Thromb Vasc Biol 2006; 26: 1236-1245
    CrossrefPubMedGoogle Scholar
  • 13 Peacock RE, Hamsten A, Nilsson-Ehle P. et al. Associations between lipoprotein lipase gene polymorphisms and plasma correlations of lipids, lipoproteins and lipase activities in young myocardial infarction survivors and age-matched healthy individuals from Sweden. Atherosclerosis 1992; 97: 171-185
    CrossrefPubMedGoogle Scholar
  • 14 Ahn YI, Kamboh MI, Hamman RF. et al. Two DNA polymorphisms in the lipoprotein lipase gene and their associations with factors related to cardiovascular disease. J Lipid Res 1993; 34: 421-428
    CrossrefPubMedGoogle Scholar
  • 15 Ma YQ, Thomas GN, Ng MC. et al. The lipoprotein lipase gene HindIII polymorphism is associated with lipid levels in early-onset type 2 diabetic patients. Metabolism 2003; 52: 338-343
    CrossrefPubMedGoogle Scholar
  • 16 Jemaa R, Fumeron F, Poirier O. et al. Lipoprotein lipase gene polymorphisms: associations with myocardial infarction and lipoprotein levels, the ECTIM study. Etude Cas Temoin sur l’Infarctus du Myocarde. J Lipid Res 1995; 36: 2141-2146
    CrossrefPubMedGoogle Scholar
  • 17 Moher D, Liberati A, Tetzlaff J. et al. Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement. PLoS Med 2009; 6: e1000097
    CrossrefPubMedGoogle Scholar
  • 18 Cho YS, Go MJ, Han HR. et al. Association of lipoprotein lipase (LPL) single nucleotide polymorphisms with type 2 diabetes mellitus. Exp Mol Med 2008; 40: 523-532
    CrossrefPubMedGoogle Scholar
  • 19 Ng MC, Baum L, So WY. et al. Association of lipoprotein lipase S447X, apolipoprotein E exon 4, and apoC3 -455T>C polymorphisms on the susceptibility to diabetic nephropathy. Clin Genet 2006; 70: 20-28
    CrossrefPubMedGoogle Scholar
  • 20 Yang T, Pang CP, Tsang MW. et al. Pathogenic mutations of the lipoprotein lipase gene in Chinese patients with hypertriglyceridemic type 2 diabetes. Hum Mutat 2003; 21: 453
    CrossrefPubMedGoogle Scholar
  • 21 Chen QZ. The case-control study on risk factor and association genes of type 2 diabetes mellitus patients. Ningxia Medical College 2006; Research Report
    PubMed
  • 22 Du PJ, Ran XJ, Chen H. et al. Association of lipoprotein lipase gene polymorphism and blood triglyceride in patients with type 2 diabetes mellitus. Chin J Diabetes Mellitus 2011; 3: 223-226
    PubMedGoogle Scholar
  • 23 Huang Y. The association between the lipoprotein lipase ser447ter polymorphism and type 2 diabetes mellitus. Shanghai Jiao Tong University 2007; Research Report
    PubMed
  • 24 Yan XJ. The association of the common gene mutations lipoprotein lipase with type 2 diabetes mellitus. Zhengzhou University 2004; Research Report
    PubMed
  • 25 Tetik Vardarli A, Harman E, Bozok Cetintas V. et al. Polymorphisms of lipid metabolism enzyme-coding genes in patients with diabetic dyslipidemia. Anatol J Cardiol 2017; 17: 313-321
    PubMedGoogle Scholar
  • 26 Li FA, Zhu M, Zhang P. et al. Association of lipoprotein lipase gene Hind III polymorphism with blood lipid and coronary heart disease in type 2 diabetes mellitus patients. J Clin Rehabil Tis Eng Res 2007; 11: 6781-6784
    PubMedGoogle Scholar
  • 27 Li DD, Su DY, Xue L. et al. Relationship between a lipoprotein lipase gene polymorphism in placental tissue and insulin resistance in patients with gestational diabetes mellitus. Genet Mol Res 2015; 14: 7751-7758
    CrossrefPubMedGoogle Scholar
  • 28 Qi Y, Liu J, Wang W. et al. The Hind III polymorphism in the lipoprotein lipase gene predicts type 2 diabetes risk among Chinese adults. Clin Chim Acta 2011; 412: 1229-1233
    CrossrefPubMedGoogle Scholar
  • 29 Du JK, Huang QY, Li SH. et al. Association of Hind III RFLP in lipoprotein lipase gene with type 2 diabetes. Hereditas 2007; 29: 929-933
    PubMedGoogle Scholar
  • 30 Li HQ, Xiao H, Zhang YM. et al. Association of polymorphism of lipoprotein lipase gene with type 2 diabetes and the lipids spectrum in Uygur. Chin J Prev Contr Chron Dis 2009; 17: 120-122
    PubMedGoogle Scholar
  • 31 Niu P. DNA polymorphism of Hind III site in the lipoprotein lipase gene in patients with type 2 diabetes mellitus and insulin resistance. Dalian Medical University 2005; Research Report
    PubMed
  • 32 Qian QW, Qian SH, Wang SJ. Polymorphism of lipoprotein lipase in han patients with diabetic coronary heart disease in Zhengzhou. J Clin Inter Med 2005; 22: 101-103
    PubMedGoogle Scholar
  • 33 Ren JM, Sun L, Liu XF. et al. Hind III polymorphism of lipoprotein lipase gene correlates with type 2 diabetes mellitus complicated coronary heart disease and insulin resistance. J Shangdong Univ (Health Sciences) 2005; 43: 301-305
    PubMedGoogle Scholar
  • 34 Xiang GD, Wang YC, Xia BS. et al. Association of lipoprotein lipase gene polymorphism and coronary heart disease in patients with type 2 diabetes mellitus. Chin J Endocrinol Metab 2001; 17: 368-369
    PubMedGoogle Scholar
  • 35 Zhang Y, Fan Y, Liu Y. et al. Polymorphism of lipoprotein lipase gene Hind III associated with type 2 diabetes. Basic. Clin Med 2004; 24: 141-144
    PubMedGoogle Scholar
  • 36 Aadila D, Tuerxun M, Zuoreguli R. et al. Association of the lipoprotein lipase gene polymorphisms with type 2 diabetes in Han nationality of Xinjiang. Chin J Geriatr 2012; 31: 778-781
    PubMedGoogle Scholar
  • 37 Pruneta-Deloche V, Marcais C, Perrot L. et al. Combination of circulating antilipoprotein lipase (Anti-LPL) antibody and heterozygous S172 fsX179 mutation of LPL gene leading to chronic hyperchylomicronemia. J Clin Endocrinol Metab 2005; 90: 3995-3998
    CrossrefPubMedGoogle Scholar
  • 38 Tkac I. Metabolic syndrome in relationship to type 2 diabetes and atherosclerosis. Diabetes Res Clin Pract 2005; 68 (Supp l1) S2-S9
    CrossrefPubMedGoogle Scholar
  • 39 Kersten S. Physiological regulation of lipoprotein lipase. Biochim Biophys Acta 2014; 1841: 919-933
    CrossrefPubMedGoogle Scholar
  • 40 Li B, Ge D, Wang Y. et al. Lipoprotein lipase gene polymorphisms and blood pressure levels in the Northern Chinese Han population. Hypertens Res 2004; 27: 373-378
    CrossrefPubMedGoogle Scholar
  • 41 Goldberg IJ. Lipoprotein lipase and lipolysis: central roles in lipoprotein metabolism and atherogenesis. J Lipid Res 1996; 37: 693-707
    CrossrefPubMedGoogle Scholar
  • 42 Humphries SE, Nicaud V, Margalef J. et al. Lipoprotein lipase gene variation is associated with a paternal history of premature coronary artery disease and fasting and postprandial plasma triglycerides: the European Atherosclerosis Research Study (EARS). Arterioscler Thromb Vasc Biol 1998; 18: 526-534
    CrossrefPubMedGoogle Scholar
  • 43 Kinnunen PK, Jackson RL, Smith LC. et al. Activation of lipoprotein lipase by native and synthetic fragments of human plasma apolipoprotein C-II. Proc Natl Acad Sci U S A 1977; 74: 4848-4851
    CrossrefPubMedGoogle Scholar
  • 44 Huang Y, Li X, Wang M. et al. Lipoprotein lipase links vitamin D, insulin resistance, and type 2 diabetes: a cross-sectional epidemiological study. Cardiovasc Diabetol 2013; 12: 17
    CrossrefPubMedGoogle Scholar
  • 45 Perseghin G, Price TB, Petersen KF. et al. Increased glucose transport-phosphorylation and muscle glycogen synthesis after exercise training in insulin-resistant subjects. N Engl J Med 1996; 335: 1357-1362
    CrossrefPubMedGoogle Scholar